Vigil Neuroscience (VIGL) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free VIGL Stock Alerts $3.54 +0.06 (+1.72%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | americanbankingnews.comVigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Up 26.0% in AprilMay 13, 2024 | americanbankingnews.comResearch Analysts Set Expectations for Vigil Neuroscience, Inc.'s Q2 2024 Earnings (NASDAQ:VIGL)May 12, 2024 | marketbeat.comVigil Neuroscience, Inc. (NASDAQ:VIGL) Sees Large Increase in Short InterestVigil Neuroscience, Inc. (NASDAQ:VIGL - Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 1,160,000 shares, a growth of 26.0% from the April 15th total of 921,000 shares. Currently, 4.6% of the shares of the company are short sold. Based on an average daily volume of 94,000 shares, the short-interest ratio is presently 12.3 days.May 11, 2024 | americanbankingnews.comResearch Analysts Set Expectations for Vigil Neuroscience, Inc.'s Q1 2025 Earnings (NASDAQ:VIGL)May 11, 2024 | americanbankingnews.comHC Wainwright Comments on Vigil Neuroscience, Inc.'s Q2 2024 Earnings (NASDAQ:VIGL)May 10, 2024 | marketbeat.comQ1 2025 Earnings Forecast for Vigil Neuroscience, Inc. Issued By Wedbush (NASDAQ:VIGL)Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Stock analysts at Wedbush issued their Q1 2025 earnings estimates for shares of Vigil Neuroscience in a research report issued to clients and investors on Wednesday, May 8th. Wedbush analyst L. Chico anticipates that the company will earn ($0May 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Vigil Neuroscience Amid Anticipated Clinical Milestones and Market Expansion OpportunitiesMay 10, 2024 | americanbankingnews.comWedbush Reiterates Outperform Rating for Vigil Neuroscience (NASDAQ:VIGL)May 10, 2024 | americanbankingnews.comVigil Neuroscience (NASDAQ:VIGL) Stock Rating Reaffirmed by HC WainwrightMay 8, 2024 | markets.businessinsider.comAnalyst Endorses Vigil Neuroscience’s VGL101 with Buy Rating Amid Promising Preliminary Data and Potential Disease ModificationMay 8, 2024 | marketbeat.comWedbush Reiterates "Outperform" Rating for Vigil Neuroscience (NASDAQ:VIGL)Wedbush reissued an "outperform" rating and set a $22.00 price objective on shares of Vigil Neuroscience in a report on Wednesday.May 8, 2024 | finanznachrichten.deVigil Neuroscience, Inc.: Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for Vigil Neuroscience Amid Strong Clinical Progress and Robust Financial PositionMay 8, 2024 | globenewswire.comVigil Neuroscience to Present at The Citizens JMP Life Sciences ConferenceMay 8, 2024 | finance.yahoo.comVigil Neuroscience Inc (VIGL) Q1 2024 Earnings: Challenges Persist Amid Clinical DevelopmentsMay 7, 2024 | globenewswire.comVigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business UpdateApril 18, 2024 | marketbeat.comJMP Securities Reaffirms Market Outperform Rating for Vigil Neuroscience (NASDAQ:VIGL)JMP Securities reiterated a "market outperform" rating and issued a $23.00 target price on shares of Vigil Neuroscience in a research report on Thursday.April 18, 2024 | markets.businessinsider.comVigil Neuroscience Inc: A Strong Buy on Promising ALSP Drug Trial Outcomes and Biomarker BreakthroughsApril 17, 2024 | globenewswire.comVigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual MeetingMarch 29, 2024 | marketbeat.comVigil Neuroscience, Inc. Forecasted to Post Q2 2024 Earnings of ($0.58) Per Share (NASDAQ:VIGL)Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Investment analysts at HC Wainwright issued their Q2 2024 earnings per share estimates for shares of Vigil Neuroscience in a research report issued on Wednesday, March 27th. HC Wainwright analyst A. Fein expects that the company will earn ($0March 29, 2024 | markets.businessinsider.comBuy Rating Affirmed for Vigil Neuroscience on Promising Clinical Trials and Key Data ReadoutsMarch 28, 2024 | marketbeat.comBrokers Issue Forecasts for Vigil Neuroscience, Inc.'s Q1 2024 Earnings (NASDAQ:VIGL)Vigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Stock analysts at HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for shares of Vigil Neuroscience in a research report issued to clients and investors on Wednesday, March 27th. HC Wainwright analyst A. Fein forecasts thMarch 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Vigil Neuroscience Inc (VIGL) and Daxor (DXR)March 27, 2024 | markets.businessinsider.comBuy Rating Affirmed: Vigil Neuroscience’s Advancing TREM2 Programs and Strong Financial PositionMarch 27, 2024 | marketbeat.comVigil Neuroscience, Inc. (NASDAQ:VIGL) Forecasted to Earn FY2028 Earnings of ($0.58) Per ShareVigil Neuroscience, Inc. (NASDAQ:VIGL - Free Report) - Investment analysts at Wedbush issued their FY2028 EPS estimates for Vigil Neuroscience in a note issued to investors on Tuesday, March 26th. Wedbush analyst L. Chico expects that the company will earn ($0.58) per share for the year. The consMarch 26, 2024 | finanznachrichten.deVigil Neuroscience, Inc.: Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 26, 2024 | msn.comVigil Neuroscience GAAP EPS of -$0.57 in-lineMarch 26, 2024 | benzinga.comVigil Neuroscience: Q4 Earnings InsightsMarch 26, 2024 | investorplace.comVIGL Stock Earnings: Vigil Neuroscience Misses EPS for Q4 2023March 26, 2024 | globenewswire.comVigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 24, 2024 | finance.yahoo.comIs Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?March 20, 2024 | finanznachrichten.deVigil Neuroscience, Inc.: Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical OfficerMarch 20, 2024 | seekingalpha.comVigil Neuroscience appoints Kaufmann as Chief Medical OfficerMarch 20, 2024 | markets.businessinsider.comVigil Neuroscience Appoints Petra Kaufmann As CMOMarch 20, 2024 | globenewswire.comVigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical OfficerMarch 16, 2024 | seekingalpha.comVIGL Vigil Neuroscience, Inc.March 13, 2024 | globenewswire.comVigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual MeetingMarch 12, 2024 | globenewswire.comVigil Neuroscience to Present at Stifel 2024 Virtual CNS DaysMarch 6, 2024 | globenewswire.comVigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024February 29, 2024 | globenewswire.comVigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024February 22, 2024 | benzinga.comVigil Neuroscience Stock (NASDAQ:VIGL) Insider TradesFebruary 15, 2024 | marketbeat.comShort Interest in Vigil Neuroscience, Inc. (NASDAQ:VIGL) Increases By 9.3%Vigil Neuroscience, Inc. (NASDAQ:VIGL - Get Free Report) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 742,000 shares, a growth of 9.3% from the January 15th total of 678,600 shares. Currently, 5.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 135,900 shares, the short-interest ratio is currently 5.5 days.February 7, 2024 | finance.yahoo.comVigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology ConferenceFebruary 7, 2024 | marketbeat.comVigil Neuroscience (NASDAQ:VIGL) Stock Price Up 6.9%Vigil Neuroscience (NASDAQ:VIGL) Trading Up 6.9%January 14, 2024 | marketbeat.comVigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest UpdateVigil Neuroscience, Inc. (NASDAQ:VIGL - Get Free Report) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 747,400 shares, a growth of 19.0% from the December 15th total of 628,100 shares. Approximately 5.8% of the company's stock are short sold. Based on an average daily volume of 126,700 shares, the days-to-cover ratio is currently 5.9 days.January 5, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: AN2 Therapeutics, Inc. (ANTX) and Vigil Neuroscience Inc (VIGL)January 4, 2024 | finanznachrichten.deVigil Neuroscience, Inc.: Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 MilestonesJanuary 3, 2024 | finance.yahoo.comVigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 MilestonesDecember 20, 2023 | msn.comMorgan Stanley Downgrades Vigil Neuroscience (VIGL)December 19, 2023 | marketbeat.comVigil Neuroscience (NASDAQ:VIGL) Lowered to "Underweight" at Morgan StanleyMorgan Stanley downgraded Vigil Neuroscience from an "equal weight" rating to an "underweight" rating and lowered their price objective for the stock from $13.00 to $4.00 in a research report on Tuesday. Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here VIGL Media Mentions By Week VIGL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VIGL News Sentiment▼0.820.55▲Average Medical News Sentiment VIGL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VIGL Articles This Week▼201▲VIGL Articles Average Week Get Vigil Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for VIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OMGA News Today LIFE News Today SGMO News Today DBVT News Today BLUE News Today VXRT News Today GRTS News Today MOLN News Today OTLK News Today CRDL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VIGL) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vigil Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
